Industries > Pharma > Global Plasma Fractionation Market 2018-2028

Global Plasma Fractionation Market 2018-2028

Immunoglobulins, Albumins, Clotting Factors, Hyperimmune Globulins, Alpha 1 Antitrypsin Inhibitors (A1PI), C1 Esterase Inhibitors, Primary Immune Deficiency (PID), Secondary Immune Deficiency (SID), Idiopathic Thrombocytopenic Purpura (ITP), Cardiac & Surgery, Emergency Medicine, Haemophilia

PUBLISHED: 01 May 2018
PAGES: 172
PRODUCT CODE: PHA0307
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0307 Categories: , Tag:

In 2017, the global plasma fractionation market was valued at $24bn and is expected to grow at a CAGR of 9.0% in the first half of the forecast period. In 2017, the immunoglobulins submarket held 44.0% of the global plasma fractionation market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 172-page report you will receive 91 tables and 98 figures– all unavailable elsewhere.

The 172-page report provides clear detailed insight into the global plasma fractionation market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Plasma Fractionation market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the global plasma fractionation market by type of product:
• Immunoglobulins
• Albumins
• Clotting Factors
• Hyperimmune Globulins
• Alpha 1 Antitrypsin Inhibitors (A1PI)
• C-1
• Others

• This report also breaks down the revenue forecast for the global plasma fractionation market by type of application:
• Primary Immune Deficiency (PID)
• Secondary Immune Deficiency (SID)
• Idiopathic Thrombocytopenic Purpura (ITP)
• Cardiac & Surgery
• Emergency Medicine
• Haemophilia

Global Plasma Fractionation Market 2018-2028

• This report also breaks down the revenue forecast for the global plasma fractionation market by regional market:
• North America
• Europe
• Latin America
• Asia-Pacific
• Middle East & Africa

• This report also breaks down the revenue forecast for the global plasma fractionation market by national market:
• US
• Canada
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Japan
• Rest of APAC

• Our study discusses the selected leading companies that are the major players in the plasma fractionation industry:
• Biotest
• CSL
• Grifols
• Kedrion
• LFB
• OctaPharma
• Shire/Baxalta
• Others

• Our study gives qualitative analysis of the plasma fractionation market. It discusses factors that drive and restrain the market

Other information included in this report:
• Type of plasma processed in Europe from 1996 – 2012 (3-year increment) for non-profit organizations (source plasma vs recovered plasma, in thousand liters)
• Type of plasma processed in Europe from 1996 – 2012 (3-year increment) for commercial companies (source plasma vs recovered plasma, in thousand liters)
• Cost of plasma protein in Canada by product
• Canadian plasma shipments for fractionation by source
• Immunoglobulin-monthly distribution and 12-month rolling average distribution (2016/2017) for: the US, the UK, Germany, Italy, Spain, Austria, Finland, Greece, Norway, Portugal, Sweden, Switzerland
• Albumin 5%-monthly distribution and 12-month rolling average distribution (2016/2017) for the US

Visiongain’s study is intended for anyone requiring commercial analyses for the global plasma fractionation market. You find data, trends and predictions.

Buy our report today Global Plasma Fractionation Market 2018-2028: Immunoglobulins, Albumins, Clotting Factors, Hyperimmune Globulins, Alpha 1 Antitrypsin Inhibitors (A1PI), C1 Esterase Inhibitors, Primary Immune Deficiency (PID), Secondary Immune Deficiency (SID), Idiopathic Thrombocytopenic Purpura (ITP), Cardiac & Surgery, Emergency Medicine, Haemophilia.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Plasma Fractionation Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Plasma Fractionation Market 2018-2028


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories